Procarbazine
Procarbazine
Definition
A methylhydrazine derivative with antineoplastic and mutagenic activities. Although the exact mode of cytotoxicity has not been elucidated, procarbazine, after metabolic activation, appears to inhibit the trans-methylation of methionine into transfer RNA (t-RNA), thereby preventing protein synthesis and consequently DNA and RNA synthesis. This agent may also undergo auto-oxidation, resulting in the formation of cytotoxic free radicals which damage DNA through an alkylation reaction.
Also known as Benzethyzin, Ibenzmethyzin, N-(1-methylethyl)-4-[(2-methylhydrazino)methyl]benzamide, N-4-isopropylcarbamoylbenzyl-N'-methylhydrazine, N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide, N-Methylhydrazine, p-(N'-methylhydrazinomethyl)-N-isopropylbenzamide, Procarbazin, PROCARBAZINE — per NCIT
Also identified as
- ATC L01XB01 per RXNORM
- NCIT NCIT:C62072 per NCIT
- SCTID 10174003 per RXNORM
- SCTID 387474003 per RXNORM
- SCTID 81583003 per RXNORM
- UNII 35S93Y190K per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Brain cancer | may treat | MEDRT · Public domain (U.S. Government work) |
| Hodgkins lymphoma | may treat | MEDRT · Public domain (U.S. Government work) |
| Lung neoplasm | may treat | MEDRT · Public domain (U.S. Government work) |
| Melanoma | may treat | MEDRT · Public domain (U.S. Government work) |
| Multiple myeloma | may treat | MEDRT · Public domain (U.S. Government work) |
| Non-Hodgkin lymphoma | may treat | MEDRT · Public domain (U.S. Government work) |
Organ Effects
| Organ | Side effect / interaction | Source |
|---|---|---|
| Lymphoid system | may treat a disease of this organ | DERIVED · CC BY 4.0 |
1 entry above is marked DERIVED: Atlas Médico inferred it by combining two sourced claims, and no source asserts this link directly. Treat it as a navigation aid, not as a clinical statement.